{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T19:03:40Z","timestamp":1785179020446,"version":"3.55.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","award":["58249"],"award-info":[{"award-number":["58249"]}],"id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.vaccine.2021.11.070","type":"journal-article","created":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T20:13:53Z","timestamp":1640204033000},"page":"275-281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Epidemiological impact of the human papillomavirus vaccination program on genital warts in Portugal: A retrospective, chart review study"],"prefix":"10.1016","volume":"40","author":[{"given":"C\u00e2ndida","family":"Fernandes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacinta","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.11.070_b0005","doi-asserted-by":"crossref","first-page":"F12","DOI":"10.1016\/j.vaccine.2012.07.055","article-title":"Global burden of human papillomavirus and related diseases","volume":"30","author":"Forman","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.11.070_b0010","unstructured":"Workowski KA, Berman S, Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep 2010 Dec 17; 59(RR-12): 1\u2013110."},{"issue":"8","key":"10.1016\/j.vaccine.2021.11.070_b0015","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1111\/jdv.14311","article-title":"Epidemiology of human papillomavirus on anogenital warts in Portugal - The HERCOLES study","volume":"31","author":"Azevedo","year":"2017","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"key":"10.1016\/j.vaccine.2021.11.070_b0020","doi-asserted-by":"crossref","unstructured":"Dominiak-Felden G, Gobbo C, Simondon F. Evaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort Study. PLoS ONE [Internet]. 2015 Jul 6 [cited 2020 Nov 26]; 10(7). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4492693\/","DOI":"10.1371\/journal.pone.0132404"},{"issue":"3","key":"10.1016\/j.vaccine.2021.11.070_b0025","first-page":"5","article-title":"An evidence-based review of medical and surgical treatments of genital warts","volume":"12","author":"Scheinfeld","year":"2006","journal-title":"Dermatol Online J"},{"issue":"6","key":"10.1016\/j.vaccine.2021.11.070_b0030","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/IGC.0b013e31821dd3b2","article-title":"CLEOPATRE Portugal Study Group. Prevalence of human papillomavirus infection in women in Portugal: the CLEOPATRE Portugal study","volume":"21","author":"Pista","year":"2011","journal-title":"Int J Gynecol Cancer Off J Int Gynecol Cancer Soc"},{"key":"10.1016\/j.vaccine.2021.11.070_b0035","doi-asserted-by":"crossref","unstructured":"Lee L, Garland SM. Human papillomavirus vaccination: the population impact. F1000Research [Internet]. 2017 Jun 12 [cited 2020 Nov 27]; 6. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5473416\/","DOI":"10.12688\/f1000research.10691.1"},{"key":"10.1016\/j.vaccine.2021.11.070_b0040","unstructured":"Direc\u00e7\u00e3o-Geral da Sa\u00fade. Programa Nacional de Vacina\u00e7\u00e3o (PNV) Introdu\u00e7\u00e3o da vacina contra infec\u00e7\u00f5es por V\u00edrus do Papiloma Humano [Internet]. 2008 [cited 2020 Nov 26]; Available from: https:\/\/www.spdc.pt\/files\/legix\/11245_3.pdf"},{"key":"10.1016\/j.vaccine.2021.11.070_b0045","unstructured":"Direc\u00e7\u00e3o-Geral da Sa\u00fade. Campanha de vacina\u00e7\u00e3o contra Infec\u00e7\u00f5es por V\u00edrus do Papiloma Humano (HPV). No 25\/DSCS\/DPCD [Internet]. 2008 [cited 2020 Nov 26]; Available from: https:\/\/nocs.pt\/vacinacao-hpv\/"},{"key":"10.1016\/j.vaccine.2021.11.070_b0050","unstructured":"Direc\u00e7\u00e3o-Geral da Sa\u00fade. Boletim Vacina\u00e7\u00e3o No10 [Internet]. 2016 [cited 2020 Nov 26]; Available from: https:\/\/www.dgs.pt\/documentos-e-publicacoes\/boletim-vacinacao-n-10-abril-de-2016-pdf.aspx"},{"key":"10.1016\/j.vaccine.2021.11.070_b0055","unstructured":"Direc\u00e7\u00e3o-Geral da Sa\u00fade. Programa Nacional de Vacina\u00e7\u00e3o - Altera\u00e7\u00e3o do esquema da vacina contra infe\u00e7\u00f5es por v\u00edrus do Papiloma humano (HPV); 2014."},{"key":"10.1016\/j.vaccine.2021.11.070_b0060","unstructured":"Direc\u00e7\u00e3o-Geral da Sa\u00fade. Atualiza\u00e7\u00e3o do Programa Nacional de Vacina\u00e7\u00e3o: PNV 2017; 2017."},{"key":"10.1016\/j.vaccine.2021.11.070_b0065","doi-asserted-by":"crossref","unstructured":"Marrazzo J, Suchland R. Recent advances in understanding and managing Chlamydia trachomatis infections. F1000Prime Rep [Internet]. 2014 Dec 1 [cited 2020 Nov 30]; 6. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4251420\/","DOI":"10.12703\/P6-120"},{"issue":"7","key":"10.1016\/j.vaccine.2021.11.070_b0070","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/cid\/cit436","article-title":"Strongly decreased risk of genital warts after vaccination against human papillomavirus: nationwide follow-up of vaccinated and unvaccinated girls in Denmark","volume":"57","author":"Blomberg","year":"2013","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am."},{"key":"10.1016\/j.vaccine.2021.11.070_b0075","doi-asserted-by":"crossref","unstructured":"Ali H, Donovan B, Wand H, Read TRH, Regan DG, Grulich AE, et al. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data. BMJ [Internet] 2013 Apr 18 [cited 2020 Nov 29]; 346. Available from: https:\/\/www.bmj.com\/content\/346\/bmj.f2032","DOI":"10.1136\/bmj.f2032"},{"issue":"7","key":"10.1016\/j.vaccine.2021.11.070_b0080","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1136\/sextrans-2013-051307","article-title":"Genital warts and chlamydia in Australian women: comparison of national population-based surveys in 2001 and 2011","volume":"90","author":"Liu","year":"2014","journal-title":"Sex Transm Infect"},{"issue":"3","key":"10.1016\/j.vaccine.2021.11.070_b0085","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/sextrans-2014-051813","article-title":"Ongoing decline in genital warts among young heterosexuals 7 years after the Australian human papillomavirus (HPV) vaccination programme","volume":"91","author":"Chow","year":"2015","journal-title":"Sex Transm Infect"},{"issue":"3","key":"10.1016\/j.vaccine.2021.11.070_b0090","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1071\/SH07042","article-title":"Modelling the population-level impact of vaccination on the transmission of human papillomavirus type 16 in Australia","volume":"4","author":"Regan","year":"2007","journal-title":"Sex Health"},{"key":"10.1016\/j.vaccine.2021.11.070_b0095","unstructured":"Direc\u00e7\u00e3o-Geral de Sa\u00fade. Programa Nacional de Vacina\u00e7\u00e3o 2020 [Internet]. 2020 [cited 2020 Nov 29]; Available from: https:\/\/www.dgs.pt\/normas-orientacoes-e-informacoes\/normas-e-circulares-normativas\/norma-n-0182020-de-27092020-pdf.aspx"}],"updated-by":[{"DOI":"10.1016\/j.vaccine.2022.04.083","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000}}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21015449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21015449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:37:34Z","timestamp":1778632654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21015449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0264410X21015449"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.11.070","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiological impact of the human papillomavirus vaccination program on genital warts in Portugal: A retrospective, chart review study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.11.070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}